Continuous treatment with odanacatib for up to 8 years in postmenopausal women with low bone mineral density: a phase 2 study
出版年份 2016 全文链接
标题
Continuous treatment with odanacatib for up to 8 years in postmenopausal women with low bone mineral density: a phase 2 study
作者
关键词
Biochemical markers of bone turnover, Bone mineral density, Cathepsin K inhibition, Clinical trial, Odanacatib, Osteoporosis
出版物
OSTEOPOROSIS INTERNATIONAL
Volume 27, Issue 6, Pages 2099-2107
出版商
Springer Nature
发表日期
2016-02-15
DOI
10.1007/s00198-016-3503-0
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Sustained Modeling-Based Bone Formation During Adulthood in Cynomolgus Monkeys May Contribute to Continuous BMD Gains With Denosumab
- (2015) Michael S Ominsky et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Odanacatib increases mineralized callus during fracture healing in a rabbit ulnar osteotomy model
- (2015) Brenda L. Pennypacker et al. JOURNAL OF ORTHOPAEDIC RESEARCH
- Inhibition of Cathepsin K Increases Modeling-Based Bone Formation, and Improves Cortical Dimension and Strength in Adult Ovariectomized Monkeys
- (2014) Brenda L Pennypacker et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effects of Odanacatib on the Radius and Tibia of Postmenopausal Women: Improvements in Bone Geometry, Microarchitecture, and Estimated Bone Strength
- (2014) Angela M Cheung et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Characterizing microarchitectural changes at the distal radius and tibia in postmenopausal women using HR-pQCT
- (2014) C. E. Kawalilak et al. OSTEOPOROSIS INTERNATIONAL
- Management of osteoporosis of the oldest old
- (2014) R. Rizzoli et al. OSTEOPOROSIS INTERNATIONAL
- Implications of Osteoblast-Osteoclast Interactions in the Management of Osteoporosis by Antiresorptive Agents Denosumab and Odanacatib
- (2014) Natalie A. Sims et al. Current Osteoporosis Reports
- The Bone Resorption Inhibitors Odanacatib and Alendronate Affect Post-Osteoclastic Events Differently in Ovariectomized Rabbits
- (2013) Pia Rosgaard Jensen et al. CALCIFIED TISSUE INTERNATIONAL
- Bone Density, Turnover, and Estimated Strength in Postmenopausal Women Treated With Odanacatib: A Randomized Trial
- (2013) Kim Brixen et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Bisphosphonate Therapy for Osteoporosis: Benefits, Risks, and Drug Holiday
- (2012) Michael McClung et al. AMERICAN JOURNAL OF MEDICINE
- Denosumab, a RANK Ligand Inhibitor, for Postmenopausal Women with Osteoporosis
- (2012) Emily E Sutton et al. ANNALS OF PHARMACOTHERAPY
- Odanacatib in the treatment of postmenopausal women with low bone mineral density: Five years of continued therapy in a phase 2 study
- (2012) Bente Langdahl et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Bisphosphonates for Osteoporosis — Where Do We Go from Here?
- (2012) Marcea Whitaker et al. NEW ENGLAND JOURNAL OF MEDICINE
- European guidance for the diagnosis and management of osteoporosis in postmenopausal women
- (2012) J. A. Kanis et al. OSTEOPOROSIS INTERNATIONAL
- Odanacatib reduces bone turnover and increases bone mass in the lumbar spine of skeletally mature ovariectomized rhesus monkeys
- (2011) Patricia J Masarachia et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Odanacatib treatment increases hip bone mass and cortical thickness by preserving endocortical bone formation and stimulating periosteal bone formation in the ovariectomized adult rhesus monkey
- (2011) Tara Cusick et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Morphea-like skin reactions in patients treated with the cathepsin K inhibitor balicatib
- (2011) Thomas M. Rnger et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
- Osteoporosis: now and the future
- (2011) Tilman D Rachner et al. LANCET
- Denosumab and bisphosphonates: Different mechanisms of action and effects
- (2010) Roland Baron et al. BONE
- Microarchitectural deterioration of cortical and trabecular bone: Differing effects of denosumab and alendronate
- (2010) Ego Seeman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Odanacatib in the treatment of postmenopausal women with low bone mineral density: Three-year continued therapy and resolution of effect
- (2010) John A Eisman et al. JOURNAL OF BONE AND MINERAL RESEARCH
- Effect of the Cathepsin K Inhibitor Odanacatib on Bone Resorption Biomarkers in Healthy Postmenopausal Women: Two Double-Blind, Randomized, Placebo-Controlled Phase I Studies
- (2009) S A Stoch et al. CLINICAL PHARMACOLOGY & THERAPEUTICS
- The discovery of odanacatib (MK-0822), a selective inhibitor of cathepsin K
- (2008) Jacques Yves Gauthier et al. BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
- Bone density, strength, and formation in adult cathepsin K (−/−) mice
- (2008) B. Pennypacker et al. BONE
- Drug-induced morphea: Report of a case induced by balicatib and review of the literature
- (2008) Anna Peroni et al. JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now